Literature DB >> 33844983

Implications of protein ubiquitination modulated by lncRNAs in gastrointestinal cancers.

Jianyuan Zhou1, Jie Liu2, Huaixin Xing3, Yue Shen4, Mengyu Xie4, Jie Chai5, Ming Yang6.   

Abstract

Long non-coding RNAs (lncRNAs) are a class of RNA transcripts longer than 200 nucleotides and mostly cannot be translated into proteins. Next-generation transcriptome sequencing of various cell types has enabled the annotation of tens of thousands of lncRNAs in human genome. Varying levels of evidence supports the implications of lncRNAs in the onset and progression of cancers. Ubiquitin is an evolutionarily conserved protein and could post-translationally mark a number of proteins. The most important proteolytic role of ubiquitination is degradation of substrate proteins by the 26S proteasome. Compiling evidences demonstrated that lncRNAs are involved in the accurate execution of protein stability programs via the ubiquitin-proteasome system. In the current review, we systematically summarize the detailed mechanisms how lncRNAs modulate ubiquitination of target proteins, regulate cancerous signaling pathways and control tumorigenesis of gastrointestinal cancers. Although there are still considerable studies on unraveling the complicated interactions between lncRNAs and proteins, we believe that lncRNAs are promising but challenging molecules which may strongly facilitate precision cancer therapeutics in the future.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Keywords:  gastrointestinal cancer; lncRNAs; oncogene; protein ubiquitination; tumor suppressor

Year:  2021        PMID: 33844983     DOI: 10.1016/j.bcp.2021.114558

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  3 in total

1.  LncRNAs LCETRL3 and LCETRL4 at chromosome 4q12 diminish EGFR-TKIs efficiency in NSCLC through stabilizing TDP43 and EIF2S1.

Authors:  Yankang Li; Yue Shen; Mengyu Xie; Bowen Wang; Teng Wang; Jiajia Zeng; Hui Hua; Jinming Yu; Ming Yang
Journal:  Signal Transduct Target Ther       Date:  2022-01-31

2.  LINC00941 promotes pancreatic cancer malignancy by interacting with ANXA2 and suppressing NEDD4L-mediated degradation of ANXA2.

Authors:  Jie Wang; Zhiwei He; Xinyuan Liu; Jian Xu; Xueyi Jiang; Gang Quan; Jianxin Jiang
Journal:  Cell Death Dis       Date:  2022-08-18       Impact factor: 9.685

3.  The Effect and Mechanism of lncRNA NR2F1-As1/miR-493-5p/MAP3K2 Axis in the Progression of Gastric Cancer.

Authors:  Xiaobin Liao; Linbao Wen; Liqiong Luo
Journal:  J Oncol       Date:  2021-07-13       Impact factor: 4.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.